Literature DB >> 24559075

Gold nanoparticle conjugates: recent advances toward clinical applications.

Roberto Cao-Milán1, Luis M Liz-Marzán.   

Abstract

INTRODUCTION: Gold nanoparticles display a unique combination of chemical inertness, surface chemistry and size- and shape-dependent electronic and optical properties, which render them ideal for clinical applications. AREAS COVERED: The present article describes recent advancements on the application of gold nanoparticles in vaccine development and gene therapy, with augmented efficiencies in cell uptake, specific binding to bioreceptors in cells, protection of conjugated biomolecules and so forth. Additionally, we discuss how the electronic structure of the nanoparticles can be exploited for enhanced radiotherapy and X-ray tomography, while their optical properties can be used for photothermal cancer therapy or light-triggered drug delivery systems for enhanced chemotherapy. EXPERT OPINION: We analyze certain critical aspects and possible challenges that should be solved in order to use gold nanoparticle conjugates in vaccine research, as well as on the potential combination of properties to improve gene therapy and cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24559075     DOI: 10.1517/17425247.2014.891582

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  32 in total

1.  Plasmonic Gold Nanostar-Enhanced Multimodal Photoacoustic Microscopy and Optical Coherence Tomography Molecular Imaging To Evaluate Choroidal Neovascularization.

Authors:  Van-Phuc Nguyen; Yanxiu Li; Jessica Henry; Wei Zhang; Michael Aaberg; Sydney Jones; Thomas Qian; Xueding Wang; Yannis M Paulus
Journal:  ACS Sens       Date:  2020-09-30       Impact factor: 7.711

2.  Evaluation of the penetration process of fluorescent collagenase nanocapsules in a 3D collagen gel.

Authors:  Víctor M Moreno; Alejandro Baeza; María Vallet-Regí
Journal:  Acta Biomater       Date:  2020-12-14       Impact factor: 8.947

3.  Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.

Authors:  Yao Hao; Sayeda Yasmin-Karim; Michele Moreau; Neeharika Sinha; Erno Sajo; Wilfred Ngwa
Journal:  Phys Med Biol       Date:  2016-12-02       Impact factor: 3.609

Review 4.  Hybrid nanoparticles for combination therapy of cancer.

Authors:  Chunbai He; Jianqin Lu; Wenbin Lin
Journal:  J Control Release       Date:  2015-09-24       Impact factor: 9.776

5.  Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model.

Authors:  Víctor M Moreno; Elena Álvarez; Isabel Izquierdo-Barba; Alejandro Baeza; Juana Serrano-Lopez; María Vallet-Regí
Journal:  Adv Mater Interfaces       Date:  2020-04-21       Impact factor: 6.147

6.  Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity.

Authors:  Chao Wang; Wandi Zhu; Yuan Luo; Bao-Zhong Wang
Journal:  Nanomedicine       Date:  2018-04-09       Impact factor: 5.307

Review 7.  Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.

Authors:  Erika Dosekova; Jaroslav Filip; Tomas Bertok; Peter Both; Peter Kasak; Jan Tkac
Journal:  Med Res Rev       Date:  2016-11-15       Impact factor: 12.944

Review 8.  Vaccine technologies: From whole organisms to rationally designed protein assemblies.

Authors:  Christopher P Karch; Peter Burkhard
Journal:  Biochem Pharmacol       Date:  2016-05-06       Impact factor: 5.858

9.  Cytotoxicity of various types of gold-mesoporous silica nanoparticles in human breast cancer cells.

Authors:  Guomu Liu; Qiongshu Li; Weihua Ni; Nannan Zhang; Xiao Zheng; Yingshuai Wang; Dan Shao; Guixiang Tai
Journal:  Int J Nanomedicine       Date:  2015-09-30

10.  In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications.

Authors:  Oshra Betzer; Rinat Meir; Tamar Dreifuss; Katerina Shamalov; Menachem Motiei; Amit Shwartz; Koby Baranes; Cyrille J Cohen; Niva Shraga-Heled; Racheli Ofir; Gal Yadid; Rachela Popovtzer
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.